ACRIN Trial Evaluates Effectiveness of Advanced MRI, CT in Liver Cancer Detection | Radiology
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

Gold Standard

Radiology ACRIN Trial Evaluates Effectiveness of Advanced MRI, CT in Liver Cancer Detection

ACRIN Trial Evaluates Effectiveness of Advanced MRI, CT in Liver Cancer Detection

Radiology News - Radiology

ACRIN recently activated ACRIN 6690: A Prospective, Multicenter Comparison of Multiphase Contrast-Enhanced CT and Multiphase Contrast-Enhanced MRI for Diagnosis of HCC and Liver Transplant Allocation.

The American College of Radiology Imaging Network (ACRIN) recently activated ACRIN 6690: A Prospective, Multicenter Comparison of Multiphase Contrast-Enhanced CT and Multiphase Contrast-Enhanced MRI for Diagnosis of Hepatocellular Carcinoma (HCC) and Liver Transplant Allocation.

A target 440 study participants will be enrolled at approximately 30 sites. The trial is endorsed by the United Network for Organ Sharing (UNOS), an organization that administers the Organ Procurement and Transplantation Network (OPTN) across the 11 transplant regions in the United States.

Two sites are actively enrolling patients and approximately 30 sites are expected to join the trial; participant enrollment is planned to be proportional to the overall contribution of each of the 11 regions to the national total of transplant patients with HCC exception points.

The trial is endorsed by the United Network for Organ Sharing (UNOS), an organization that administers the Organ Procurement and Transplantation Network (OPTN) made up of 11 regions across the United States.

Source: ACR

 

Related Articles